Inventor
QIAN XIANGPING
US92 patents
⚠️ This page may combine multiple inventors who share the name “QIAN XIANGPING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUPHARMA INC
19 patentsUS10172868B2Jan 8, 2019
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC10 citations92
US9849139B2Dec 26, 2017
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC12 citations92
US9572808B2Feb 21, 2017
Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
NEUPHARMA INC13 citations92
US9550770B2Jan 24, 2017
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC15 citations92
US11304957B2Apr 19, 2022
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC4 citations84
US10653701B2May 19, 2020
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC7 citations84
US10544106B2Jan 28, 2020
Certain chemical entities, compositions, and methods
NEUPHARMA INC7 citations84
US10065986B2Sep 4, 2018
Certain chemical entities, compositions, and methods
NEUPHARMA INC6 citations84
US9725421B2Aug 8, 2017
Substituted quinoxalines as B-raf kinase inhibitors
NEUPHARMA INC6 citations84
US9688635B2Jun 27, 2017
Certain chemical entities, compositions, and methods
NEUPHARMA INC10 citations84
US9676813B2Jun 13, 2017
Certain steroids and methods for using the same in the treatment of cancer
NEUPHARMA INC9 citations84
US9670180B2Jun 6, 2017
Certain chemical entities, compositions, and methods
NEUPHARMA INC9 citations84
US9249111B2Feb 2, 2016
Substituted quinoxalines as B-RAF kinase inhibitors
NEUPHARMA INC13 citations84
US9249110B2Feb 2, 2016
Substituted quinoxalines as B-raf kinase inhibitors
NEUPHARMA INC13 citations84
US9908866B2Mar 6, 2018
Certain chemical entities, compositions, and methods
NEUPHARMA INC5 citations76
US11865120B2Jan 9, 2024
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC2 citations73
US11208388B2Dec 28, 2021
Certain chemical entities, compositions, and methods
NEUPHARMA INC2 citations73
US10947201B2Mar 16, 2021
Certain chemical entities, compositions, and methods
NEUPHARMA INC6 citations73
US10561652B2Feb 18, 2020
Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
NEUPHARMA INC1 citations73
CYTOKINETICS INC
12 patentsUS7888373B2Feb 15, 2011
Heterocyclic sulfonamides as modulators of cardiac sarcomeres
CYTOKINETICS INC40 citations96
US7595322B2Sep 29, 2009
Heterocyclic sulfonamides as modulators of cardiac sarcomeres
CYTOKINETICS INC41 citations96
US10076519B2Sep 18, 2018
Substituted pyridazines as skeletal muscle modulators
CYTOKINETICS INC16 citations92
US9730886B2Aug 15, 2017
Amino-pyrimidine skeletal muscle modulators
CYTOKINETICS INC17 citations92
US9604965B2Mar 28, 2017
Substituted pyridazines as skeletal muscle modulators
CYTOKINETICS INC20 citations92
US7504413B2Mar 17, 2009
N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
CYTOKINETICS INC14 citations92
US7491826B2Feb 17, 2009
Compounds, compositions and methods
CYTOKINETICS INC27 citations92
US7399866B2Jul 15, 2008
Compounds, compositions, and methods
CYTOKINETICS INC29 citations92
US10765624B2Sep 8, 2020
Amino-pyrimidine skeletal muscle modulators
CYTOKINETICS INC5 citations84
US10272030B2Apr 30, 2019
Amino-pyrimidine skeletal muscle modulators
CYTOKINETICS INC6 citations84
US7939548B2May 10, 2011
Certain chemical entities, compositions, and methods
CYTOKINETICS INC7 citations84
US11369565B2Jun 28, 2022
Amino-pyrimidine skeletal muscle modulators
CYTOKINETICS INC1 citations73
QIAN XIANGPING
6 patentsUS9340570B2May 17, 2016
Certain chemical entities, compositions, and methods
QIAN XIANGPING12 citations92
US8334376B2Dec 18, 2012
Certain chemical entities, compositions, and methods
QIAN XIANGPING19 citations92
US8088793B2Jan 3, 2012
Certain chemical entities, compositions, and methods
QIAN XIANGPING20 citations91
US9518029B2Dec 13, 2016
Certain chemical entities, compositions, and methods
QIAN XIANGPING10 citations84
US9493503B2Nov 15, 2016
Certain chemical entities, compositions, and methods
QIAN XIANGPING10 citations84
US9018197B2Apr 28, 2015
Tetradecahydro-1H-cyclopenta[a]phenanthrene compounds, compositions, and related methods of use
QIAN XIANGPING9 citations84
SUZHOU NEUPHARMA CO LTD
5 patentsUS9399659B2Jul 26, 2016
Certain chemical entities, compositions, and methods
SUZHOU NEUPHARMA CO LTD12 citations92
US8993550B2Mar 31, 2015
Certain chemical entities, compositions, and methods
SUZHOU NEUPHARMA CO LTD15 citations92
US10179141B2Jan 15, 2019
Certain chemical entities, compositions, and methods
SUZHOU NEUPHARMA CO LTD6 citations84
US9814735B2Nov 14, 2017
Certain chemical entities, compositions, and methods
SUZHOU NEUPHARMA CO LTD7 citations84
US10471078B2Nov 12, 2019
Certain chemical entities, compositions, and methods
SUZHOU NEUPHARMA CO LTD1 citations73
ASHCRAFT LUKE W
5 patentsUS9133123B2Sep 15, 2015
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
ASHCRAFT LUKE W24 citations92
US8969346B2Mar 3, 2015
Amino-pyridazine skeletal muscle modulators
ASHCRAFT LUKE W23 citations91
US9278962B2Mar 8, 2016
Certain heterocycles, compositions thereof, and methods for their use
ASHCRAFT LUKE W7 citations83
US8759380B2Jun 24, 2014
Certain heterocycles, compositions thereof, and methods for their use
ASHCRAFT LUKE W10 citations83
US8686007B2Apr 1, 2014
Certain heterocycles, compositions thereof, and methods for their use
ASHCRAFT LUKE W15 citations83
MORGAN BRADLEY PAUL
1 patentYANG ZHE
1 patentZHU YONG-LIANG
1 patentShowing the top 50 of 92 patents by PatentIndex Score.